Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for refractory cancer pain in palliative care
ACTRN12607000501448Phase 3Completed
- Sponsor
- Flinders University
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cancer pain comparing Ketamine with Placebo (2 arms). Primary endpoint: Pain score. Started Mar 2008; status: completed.
02
Drugs
ketamine
03
Conditions
cancer pain
Beyond the preview
Go deeper on ACTRN12607000501448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000501448.